Human pluripotent stem cells (hPSCs) are currently used in clinical applications such as
cardiac regenerative therapy, studying disease models, and drug screening for heart failure …

Pluripotent stem cells (PSCs), which include embryonic stem cells and induced pluripotent
stem cells, have the potential for unlimited self-renewal and proliferation and the ability to …

Patient-derived human pluripotent stem cell-derived cardiomyocytes (hPSC-CMs) are
increasingly being used for disease modeling, drug screening and regenerative medicine …

Growing evidence indicates that metabolites and energy metabolism play an active rather
than consequential role in regulating cellular fate. Cardiac development requires dramatic …

Cardiomyocytes derived from human pluripotent stem cells (hPSCs) are emerging as an
invaluable alternative to primarily sourced cardiomyocytes. The potentially unlimited number …

Human pluripotent stem cell derived cardiomyocytes (hPSC-CMs) represent an
inexhaustible cell source for in vitro disease modeling, drug discovery and toxicity …

Human-induced pluripotent stem cells (h-iPSCs) are a unique in vitro model for
cardiovascular research. To realize the potential applications of h-iPSCs-derived …

Pluripotent stem cells (PSCs) exhibit promising application in regenerative therapy, drug
discovery, and disease modeling. While several protocols for differentiating somatic cells …

The human heart is considered a non-regenerative organ. Worldwide, cardiovascular
diseases continue to be the leading cause of death. Despite advances in cardiac treatment …

The number of patients with heart failure (HF) is increasing with aging in our society
worldwide. Patients with HF who are resistant to medication and device therapy are …